Cargando…

The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study

Postoperative spinal patients remain a challenge for provision of postoperative analgesia. Patient-controlled intravenous analgesia (PCIA) is a major method in reducing the severe pain after the surgery in our institution, but some adverse effects prevent the use of adequate dosage opioids. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Chun-Shan, Lu, Yao, Zhang, Jun, Sun, Peng, Yu, Jun-Ma, Wu, Chao, Lu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265895/
https://www.ncbi.nlm.nih.gov/pubmed/27684802
http://dx.doi.org/10.1097/MD.0000000000004776
_version_ 1782500360271691776
author Dong, Chun-Shan
Lu, Yao
Zhang, Jun
Sun, Peng
Yu, Jun-Ma
Wu, Chao
Lu, Qiang
author_facet Dong, Chun-Shan
Lu, Yao
Zhang, Jun
Sun, Peng
Yu, Jun-Ma
Wu, Chao
Lu, Qiang
author_sort Dong, Chun-Shan
collection PubMed
description Postoperative spinal patients remain a challenge for provision of postoperative analgesia. Patient-controlled intravenous analgesia (PCIA) is a major method in reducing the severe pain after the surgery in our institution, but some adverse effects prevent the use of adequate dosage opioids. This study was determined using the probit analysis to investigate the optimal dose of dexmedetomidine (DEX) infusion for postoperative analgesia combined with sufentanil (SUF) in spine surgery. The dose of DEX needed to produce satisfactory analgesia conditions following combination of 3.0 μg/kg SUF in PCIA pump, which was diluted to 250 mL with a 4 mL/h as background infusion. Patients were recruited with age 35 to 65 years. The satisfactory criteria of postoperative analgesia were determined with a average satisfaction level of pain control, sedation, self-satisfaction, and adverse effects, among others. The dose of DEX was determined using the modified Dixon's up-and-down method (0.5 μg/kg as a step size). The first patient was test at 3.0 μg/kg DEX. The patient was assessed at 6, 12, 36 hours, and termination of PCIA following the continuous infusion of DEX-SUF mixture in PCIA after surgery. Twenty-five patients were enrolled by predetermined criteria. The optimal dose of DEX required for satisfactory analgesic was 4.33 (SD, 0.38) μg/kg combined with 3.0 μg/kg SUF via a PCIA volume of 250 mL by background infusion of 4 mL/h. Using probit analysis, the ED(50) of DEX was 4.12 μg/kg (95% confidence limits 3.74–4.52 μg/kg) for satisfactory postoperative analgesic in spine surgery, the ED(95) of DEX was 4.85 μg/kg (95% confidence limits 4.48–7.13 μg/kg). There was no report of somnolence or respiratory depression, relevant bradycardia or hypotension, or over sedation in this study. The optimal dose of DEX was 4.33 (0.38) μg/kg(−1) combined with 3.0 μg/kg(−1) SUF diluted to 250 mL with a background infusion of 4 mL/h for satisfactory analgesic after spine surgery. From probit analysis, ED(50) and ED(95) of DEX were 4.12 μg/kg (95% confidence limits 3.74–4.52 μg/kg) and 4.85 μg.kg(−1) (95% confidence limits 4.48–7.13 μg/kg), respectively.
format Online
Article
Text
id pubmed-5265895
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-52658952017-02-06 The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study Dong, Chun-Shan Lu, Yao Zhang, Jun Sun, Peng Yu, Jun-Ma Wu, Chao Lu, Qiang Medicine (Baltimore) 3300 Postoperative spinal patients remain a challenge for provision of postoperative analgesia. Patient-controlled intravenous analgesia (PCIA) is a major method in reducing the severe pain after the surgery in our institution, but some adverse effects prevent the use of adequate dosage opioids. This study was determined using the probit analysis to investigate the optimal dose of dexmedetomidine (DEX) infusion for postoperative analgesia combined with sufentanil (SUF) in spine surgery. The dose of DEX needed to produce satisfactory analgesia conditions following combination of 3.0 μg/kg SUF in PCIA pump, which was diluted to 250 mL with a 4 mL/h as background infusion. Patients were recruited with age 35 to 65 years. The satisfactory criteria of postoperative analgesia were determined with a average satisfaction level of pain control, sedation, self-satisfaction, and adverse effects, among others. The dose of DEX was determined using the modified Dixon's up-and-down method (0.5 μg/kg as a step size). The first patient was test at 3.0 μg/kg DEX. The patient was assessed at 6, 12, 36 hours, and termination of PCIA following the continuous infusion of DEX-SUF mixture in PCIA after surgery. Twenty-five patients were enrolled by predetermined criteria. The optimal dose of DEX required for satisfactory analgesic was 4.33 (SD, 0.38) μg/kg combined with 3.0 μg/kg SUF via a PCIA volume of 250 mL by background infusion of 4 mL/h. Using probit analysis, the ED(50) of DEX was 4.12 μg/kg (95% confidence limits 3.74–4.52 μg/kg) for satisfactory postoperative analgesic in spine surgery, the ED(95) of DEX was 4.85 μg/kg (95% confidence limits 4.48–7.13 μg/kg). There was no report of somnolence or respiratory depression, relevant bradycardia or hypotension, or over sedation in this study. The optimal dose of DEX was 4.33 (0.38) μg/kg(−1) combined with 3.0 μg/kg(−1) SUF diluted to 250 mL with a background infusion of 4 mL/h for satisfactory analgesic after spine surgery. From probit analysis, ED(50) and ED(95) of DEX were 4.12 μg/kg (95% confidence limits 3.74–4.52 μg/kg) and 4.85 μg.kg(−1) (95% confidence limits 4.48–7.13 μg/kg), respectively. Wolters Kluwer Health 2016-09-30 /pmc/articles/PMC5265895/ /pubmed/27684802 http://dx.doi.org/10.1097/MD.0000000000004776 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 3300
Dong, Chun-Shan
Lu, Yao
Zhang, Jun
Sun, Peng
Yu, Jun-Ma
Wu, Chao
Lu, Qiang
The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study
title The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study
title_full The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study
title_fullStr The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study
title_full_unstemmed The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study
title_short The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study
title_sort optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: a probit analysis study
topic 3300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265895/
https://www.ncbi.nlm.nih.gov/pubmed/27684802
http://dx.doi.org/10.1097/MD.0000000000004776
work_keys_str_mv AT dongchunshan theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT luyao theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT zhangjun theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT sunpeng theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT yujunma theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT wuchao theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT luqiang theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT dongchunshan optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT luyao optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT zhangjun optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT sunpeng optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT yujunma optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT wuchao optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy
AT luqiang optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy